Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)Kamran Ghoreschi(National Institutes of Health), John J. O’Shea(National Institutes of Health)The Journal of ImmunologyMarch 8, 201110.4049/jimmunol.1003668Cited by 634SaveCiteExport RISWatch citationsRelated PapersNutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activation|Scientific Reports|2017|353D chromatin architecture, BRD4, and Mediator have distinct roles in regulating genome-wide transcriptional bursting and gene network|Science Advances|2024|16Paxbp1 restrains cytotoxic and innate cell programs in CD4+ T cells to promote Th2 differentiation|Research Square|2025|0